The Procter & Gamble Company (NYSE:PG - Get Free Report)'s stock price shot up 2.1% during trading on Friday after Wells Fargo & Company raised their price target on the stock from $188.00 to $190.00. Wells Fargo & Company currently has an overweight rating on the stock. Procter & Gamble traded as high as $176.49 and last traded at $176.45. 2,250,734 shares were traded during mid-day trading, a decline of 66% from the average session volume of 6,650,751 shares. The stock had previously closed at $172.75.
Several other analysts also recently issued reports on the stock. Barclays downgraded shares of Procter & Gamble from an "overweight" rating to an "equal weight" rating and set a $163.00 price objective for the company. in a research note on Monday, September 30th. Hsbc Global Res raised Procter & Gamble to a "strong-buy" rating in a research note on Friday, October 4th. Royal Bank of Canada reaffirmed a "sector perform" rating and set a $164.00 target price on shares of Procter & Gamble in a research report on Monday, October 21st. Piper Sandler started coverage on Procter & Gamble in a research note on Tuesday, September 24th. They set a "neutral" rating and a $174.00 price target on the stock. Finally, JPMorgan Chase & Co. increased their target price on shares of Procter & Gamble from $179.00 to $186.00 and gave the stock an "overweight" rating in a report on Thursday, September 19th. Nine research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $178.00.
Check Out Our Latest Stock Analysis on Procter & Gamble
Insider Buying and Selling
In related news, insider Susan Street Whaley sold 634 shares of Procter & Gamble stock in a transaction that occurred on Wednesday, October 2nd. The shares were sold at an average price of $171.65, for a total value of $108,826.10. Following the completion of the transaction, the insider now owns 19,341 shares in the company, valued at $3,319,882.65. The trade was a 3.17 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Andre Schulten sold 13,041 shares of the business's stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $170.00, for a total transaction of $2,216,970.00. Following the sale, the chief financial officer now owns 37,208 shares of the company's stock, valued at $6,325,360. This represents a 25.95 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 160,693 shares of company stock valued at $27,311,345. Corporate insiders own 0.18% of the company's stock.
Institutional Trading of Procter & Gamble
Institutional investors have recently added to or reduced their stakes in the business. Itau Unibanco Holding S.A. purchased a new stake in shares of Procter & Gamble during the second quarter worth $28,000. Fairway Wealth LLC bought a new position in shares of Procter & Gamble in the second quarter valued at approximately $29,000. RPg Family Wealth Advisory LLC bought a new stake in shares of Procter & Gamble in the third quarter valued at approximately $33,000. POM Investment Strategies LLC bought a new stake in shares of Procter & Gamble in the 2nd quarter worth approximately $34,000. Finally, Quest Partners LLC bought a new stake in shares of Procter & Gamble during the second quarter valued at approximately $36,000. Institutional investors own 65.77% of the company's stock.
Procter & Gamble Price Performance
The stock's 50 day simple moving average is $170.00 and its two-hundred day simple moving average is $168.54. The stock has a market cap of $415.08 billion, a price-to-earnings ratio of 30.42, a P/E/G ratio of 3.69 and a beta of 0.42. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.75 and a quick ratio of 0.55.
Procter & Gamble (NYSE:PG - Get Free Report) last announced its quarterly earnings results on Friday, October 18th. The company reported $1.93 EPS for the quarter, beating the consensus estimate of $1.90 by $0.03. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The business had revenue of $21.74 billion for the quarter, compared to analyst estimates of $21.99 billion. During the same quarter in the previous year, the firm earned $1.83 EPS. Procter & Gamble's quarterly revenue was down .6% on a year-over-year basis. On average, analysts forecast that The Procter & Gamble Company will post 6.94 earnings per share for the current fiscal year.
Procter & Gamble Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Friday, October 18th were issued a $1.0065 dividend. This represents a $4.03 annualized dividend and a yield of 2.28%. The ex-dividend date of this dividend was Friday, October 18th. Procter & Gamble's dividend payout ratio is 69.48%.
About Procter & Gamble
(
Get Free Report)
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.